Paul Gilman

2.5k total citations · 1 hit paper
37 papers, 1.8k citations indexed

About

Paul Gilman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Paul Gilman has authored 37 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Genetics. Recurrent topics in Paul Gilman's work include Cancer Treatment and Pharmacology (9 papers), BRCA gene mutations in cancer (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Paul Gilman is often cited by papers focused on Cancer Treatment and Pharmacology (9 papers), BRCA gene mutations in cancer (4 papers) and Lung Cancer Treatments and Mutations (4 papers). Paul Gilman collaborates with scholars based in United States, Canada and India. Paul Gilman's co-authors include Camilo E. Fadul, Stewart B. Fleishman, Charles L. Shapiro, Electra D. Paskett, Constance Cirrincione, Herbert Pang, Elizabeth Smith, Linda R. Bressler, Tim A. Ahles and Nguyet Le‐Lindqwister and has published in prestigious journals such as Science, JAMA and Journal of Biological Chemistry.

In The Last Decade

Paul Gilman

36 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy

2013 718 citations Elizabeth Smith, Herbert Pang et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Gilman United States	14	1.1k	335	290	283	273	37	1.8k
John C. Michalak United States	19	1.0k 0.9×	242 0.7×	216 0.7×	319 1.1×	367 1.3×	24	1.9k
Gregoris Iconomou Greece	26	1.3k 1.1×	103 0.3×	295 1.0×	231 0.8×	410 1.5×	62	2.5k
Marina Elena Cazzaniga Italy	28	2.1k 1.9×	389 1.2×	279 1.0×	217 0.8×	639 2.3×	138	3.2k
Jeffrey K. Giguere United States	22	1.4k 1.3×	284 0.8×	116 0.4×	185 0.7×	795 2.9×	66	2.2k
B. Jandolo Italy	24	548 0.5×	130 0.4×	181 0.6×	99 0.3×	323 1.2×	62	1.8k
E. Terzoli Italy	29	1.9k 1.7×	130 0.4×	108 0.4×	140 0.5×	644 2.4×	102	2.8k
Matthias Weiss United States	17	840 0.8×	207 0.6×	82 0.3×	78 0.3×	149 0.5×	46	1.4k
Violante E. Currie United States	25	1.8k 1.6×	135 0.4×	282 1.0×	69 0.2×	449 1.6×	41	2.6k
Jean-Louis Misset France	22	1.6k 1.5×	283 0.8×	108 0.4×	210 0.7×	513 1.9×	42	2.5k
Nguyet Le‐Lindqwister United States	16	1.1k 1.0×	59 0.2×	445 1.5×	482 1.7×	217 0.8×	29	1.6k

Countries citing papers authored by Paul Gilman

Since Specialization

Citations

This map shows the geographic impact of Paul Gilman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Gilman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Gilman more than expected).

Fields of papers citing papers by Paul Gilman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Gilman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Gilman. The network helps show where Paul Gilman may publish in the future.

Co-authorship network of co-authors of Paul Gilman

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Gilman. A scholar is included among the top collaborators of Paul Gilman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Gilman. Paul Gilman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stearns, Vered, Opeyemi A. Jegede, Victor T. Chang, et al.. (2024). A Cohort Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms: Results from ECOG-ACRIN E1Z11. Clinical Cancer Research. 30(13). 2709–2718. 4 indexed citations

Weiss, Marisa C., Sherry Danese, Theresa McHugh, et al.. (2021). A Coala‐T‐Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment. Cancer. 128(1). 160–168. 36 indexed citations

Wang, Yue, et al.. (2019). The quest for reliable prediction of chemotherapy-induced delayed nausea among breast cancer patients. 2019. 2 indexed citations

Fox, Eric E., Thomas Oliver, Sunil Thomas, et al.. (2018). Indoximod: An Immunometabolic Adjuvant That Empowers T Cell Activity in Cancer. Frontiers in Oncology. 8. 370–370. 99 indexed citations

Yang, Ning, Paul Gilman, Razmik Mirzayans, et al.. (2015). Characterization of the Apoptotic Response Induced by the Cyanine Dye D112: A Potentially Selective Anti-Cancer Compound. PLoS ONE. 10(4). e0125381–e0125381. 6 indexed citations

Smith, Elizabeth, Herbert Pang, Constance Cirrincione, et al.. (2013). Effect of Duloxetine on Pain, Function, and Quality of Life Among Patients With Chemotherapy-Induced Painful Peripheral Neuropathy. JAMA. 309(13). 1359–1359. 718 indexed citations breakdown →

Guo, Ying, Desirée Jones, J. Lynn Palmer, et al.. (2013). Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial. Supportive Care in Cancer. 22(5). 1223–1231. 83 indexed citations

Smith, Elizabeth, Herbert Pang, Constance Cirrincione, et al.. (2012). CALGB 170601: A phase III double blind trial of duloxetine to treat painful chemotherapy-induced peripheral neuropathy (CIPN).. Journal of Clinical Oncology. 30(15_suppl). CRA9013–CRA9013. 10 indexed citations

Shen, Xinglei, Albert S. DeNittis, Maria Werner‐Wasik, et al.. (2011). Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma. Radiation Oncology. 6(1). 17–17. 7 indexed citations

10.

Lamb, Kathleen M., et al.. (2011). Full-Term Pregnancy and Vaginal Delivery After Treatment for Non-Hodgkin’s Lymphoma of the Cervix and Lower Uterine Segment: A Case Report. Journal of Obstetrics and Gynaecology Canada. 33(6). 620–624. 10 indexed citations

11.

Katz, Jonathan L., et al.. (2010). Feasibility of an exercise program for aromatase inhibitor-related arthralgia (AIRA) in breast cancer survivors.. Journal of Clinical Oncology. 28(15_suppl). TPS101–TPS101. 2 indexed citations

12.

Fisch, Michael, Ju‐Whei Lee, Judith Manola, et al.. (2009). Survey of disease and treatment-related symptoms in outpatients with invasive cancer of the breast, prostate, lung, or colon/rectum (E2Z02, the SOAPP study). Journal of Clinical Oncology. 27(15_suppl). 9619–9619. 3 indexed citations

13.

Sabel, Allison L., et al.. (2008). Cancer Genetics Evaluation: Barriers to and Improvements for Referral. Genetic Testing. 12(1). 9–12. 38 indexed citations

14.

Gilman, Paul. (2008). A REVIEW OF THE SPECTRAL SENSITIZATION OF SILVER HALIDES, PAST AND PRESENT*. Photochemistry and Photobiology. 16(4). 211–218. 2 indexed citations

15.

Gilman, Paul, et al.. (2005). Cancer genetics evaluation: Barriers to and improvements for referral. Journal of Clinical Oncology. 23(16_suppl). 6109–6109.

16.

Dabrow, Michael B., et al.. (2003). Combined Therapy with Topotecan and Gemcitabine in Patients with Inoperable or Metastatic Non-small Cell Lung Cancer. Cancer Investigation. 21(4). 517–525. 16 indexed citations

17.

Hartmann, Ellen, et al.. (2002). Motivations and Concerns of Women Considering Genetic Testing for Breast Cancer: A Comparison Between Affected and At-Risk Probands. Genetic Testing. 6(3). 203–205. 24 indexed citations

18.

Kelley, Roger E., et al.. (1984). Cerebral Ischemia in the Presence of Lupus Anticoagulant. Archives of Neurology. 41(5). 521–523. 20 indexed citations

19.

Martínez, Juan‐Pablo, P.M. Keane, Paul Gilman, & Joseph E. Palascak. (1983). THE ABNORMAL CARBOHYDRATE COMPOSITION OF THE DYSFIBRINOGENEMIA ASSOCIATED WITH LIVER DISEASE*. Annals of the New York Academy of Sciences. 408(1). 388–396. 27 indexed citations

20.

Gilman, Paul, et al.. (1973). Luminescent Evidence for the Hole-Trapping Mechanism Supersensitization of J-Aggregates. The Journal of Photographic Science. 21(2). 53–70. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact